Efficacy and early complications of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation.
Pakakasama
Samart
S
Faculty of Medicine Ramathibodi, Bangkok, Thailand. rasam@mahidol.ac.th
Chuansumrit
Ampaiwan
A
Damkong
Butsakorn
B
Sirachainan
Nongnuch
N
Sirireung
Somtawin
S
Hongeng
Suradej
S
D002066:Busulfan / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D019172:Transplantation Conditioning / Q000379:methods*; D017086:beta-Thalassemia / Q000601:surgery*
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D002066:Busulfan